Latest Insider Transactions at Healthstream Inc (HSTM)
This section provides a real-time view of insider transactions for Healthstream Inc (HSTM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HEALTHSTREAM INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HEALTHSTREAM INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Jeff Cunningham Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,607
-8.02%
|
$41,782
$26.25 P/Share
|
|
Mar 23
2023
|
Jeff Cunningham Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,630
+24.87%
|
-
|
|
Mar 23
2023
|
Kevin P O'Hara Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
883
-14.19%
|
$22,958
$26.25 P/Share
|
|
Mar 23
2023
|
Kevin P O'Hara Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,626
+36.81%
|
-
|
|
Mar 23
2023
|
Michael Scott Mc Quigg Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,615
-10.34%
|
$41,990
$26.25 P/Share
|
|
Mar 23
2023
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
6,630
+29.8%
|
-
|
|
Mar 23
2023
|
Scott Fenstermacher Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,725
-15.29%
|
$44,850
$26.25 P/Share
|
|
Mar 23
2023
|
Scott Fenstermacher Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,062
+30.97%
|
-
|
|
Mar 23
2023
|
Scott Alexander Roberts CFO and SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,362
-8.49%
|
$35,412
$26.25 P/Share
|
|
Mar 23
2023
|
Scott Alexander Roberts CFO and SVP |
BUY
Exercise of conversion of derivative security
|
Direct |
5,634
+25.99%
|
-
|
|
Mar 10
2023
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+0.12%
|
$6,000
$25.04 P/Share
|
|
Feb 24
2023
|
Tate Deborah Taylor Director |
SELL
Open market or private sale
|
Direct |
3,374
-15.43%
|
$84,350
$25.26 P/Share
|
|
Jan 30
2023
|
Michael Scott Mc Quigg Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
675
-6.99%
|
$15,525
$23.45 P/Share
|
|
Jan 30
2023
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,275
+19.06%
|
-
|
|
Jan 30
2023
|
Scott Fenstermacher Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
183
-2.86%
|
$4,209
$23.45 P/Share
|
|
Jan 30
2023
|
Scott Fenstermacher Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
474
+6.89%
|
-
|
|
Jan 12
2023
|
Kevin P O'Hara Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
482
-15.65%
|
$11,568
$24.07 P/Share
|
|
Jan 12
2023
|
Kevin P O'Hara Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+34.54%
|
-
|
|
Dec 16
2022
|
Robert A Frist Jr CEO and Chairman |
SELL
Bona fide gift
|
Direct |
6,800
-0.14%
|
-
|
|
Dec 14
2022
|
Trisha L Coady Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-1.94%
|
$7,475
$25.21 P/Share
|
|
Dec 14
2022
|
Trisha L Coady Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,225
+7.37%
|
-
|
|
Dec 12
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
227
+0.18%
|
$5,448
$24.83 P/Share
|
|
Dec 12
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
201
+0.41%
|
$4,824
$24.83 P/Share
|
|
Dec 12
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
201
+0.1%
|
$4,824
$24.83 P/Share
|
|
Dec 02
2022
|
Tate Deborah Taylor Director |
SELL
Bona fide gift
|
Direct |
394
-1.77%
|
-
|
|
Dec 01
2022
|
Tate Deborah Taylor Director |
SELL
Bona fide gift
|
Direct |
197
-0.88%
|
-
|
|
Sep 20
2022
|
Scott Alexander Roberts CFO and SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
256
-2.4%
|
$5,376
$21.93 P/Share
|
|
Sep 20
2022
|
Scott Alexander Roberts CFO and SVP |
BUY
Exercise of conversion of derivative security
|
Direct |
1,050
+8.96%
|
-
|
|
Sep 20
2022
|
Michael Manning Collier Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
183
-0.77%
|
$3,843
$21.93 P/Share
|
|
Sep 20
2022
|
Michael Manning Collier Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+3.06%
|
-
|
|
Sep 12
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
250
+0.51%
|
$5,500
$22.5 P/Share
|
|
Sep 12
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
417
+0.33%
|
$9,174
$22.5 P/Share
|
|
Sep 12
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
267
+0.14%
|
$5,874
$22.5 P/Share
|
|
Jul 29
2022
|
Jeffrey L Mclaren Director |
SELL
Open market or private sale
|
Direct |
5,000
-27.68%
|
$120,000
$24.17 P/Share
|
|
Jun 24
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
236
+0.19%
|
$4,956
$21.22 P/Share
|
|
Jun 24
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
236
+0.49%
|
$4,956
$21.22 P/Share
|
|
Jun 24
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
236
+0.12%
|
$4,956
$21.22 P/Share
|
|
Jun 10
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
497
+0.25%
|
$9,940
$20.12 P/Share
|
|
Jun 10
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
528
+0.42%
|
$10,560
$20.12 P/Share
|
|
Jun 10
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
528
+1.09%
|
$10,560
$20.12 P/Share
|
|
Mar 17
2022
|
Frank Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+1.34%
|
-
|
|
Mar 17
2022
|
Thompson Dent Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+2.06%
|
-
|
|
Mar 17
2022
|
Linda Rebrovick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+5.34%
|
-
|
|
Mar 17
2022
|
Michael D Shmerling Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+2.08%
|
-
|
|
Mar 17
2022
|
William Stead Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+6.98%
|
-
|
|
Mar 17
2022
|
Tate Deborah Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+10.65%
|
-
|
|
Mar 17
2022
|
Robert A Frist Jr CEO and Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,291
-0.03%
|
$24,529
$19.94 P/Share
|
|
Mar 17
2022
|
Robert A Frist Jr CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,298
+0.11%
|
-
|
|
Mar 17
2022
|
Trisha L Coady Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-6.42%
|
$18,487
$19.94 P/Share
|
|
Mar 17
2022
|
Trisha L Coady Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,072
+21.18%
|
-
|